483 Document: Boehringer Ingelheim Fremont, Inc., Nov 4, 2022

FDANews 483 Boehringer Ingelheim Fremont, Inc. Nov 4 2022 top
Jeffrey P. Raimondi FDA Investigator Christopher R. Czajka FDA Investigator

On Nov 04, 2022, the FDA inspected Boehringer Ingelheim Fremont, Inc.'s Fremont site. Explore the inspectional observations.